Alikem Limited (AKE.CA) Stock Fundamental Analysis

TSX:AKE • AU0000193666

8.86 CAD
-0.05 (-0.56%)
Last: Dec 21, 2023, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

Overall AKE gets a fundamental rating of 7 out of 10. We evaluated AKE against 802 industry peers in the Metals & Mining industry. AKE gets an excellent profitability rating and is at the same time showing great financial health properties. An interesting combination arises when we look at growth and value: AKE is growing strongly while it also seems undervalued. With these ratings, AKE could be worth investigating further for value and growth and quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year AKE was profitable.
  • In the past year AKE had a positive cash flow from operations.
  • In multiple years AKE reported negative net income over the last 5 years.
  • In multiple years AKE reported negative operating cash flow during the last 5 years.
AKE.CA Yearly Net Income VS EBIT VS OCF VS FCFAKE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 8.47%, AKE belongs to the top of the industry, outperforming 94.81% of the companies in the same industry.
  • AKE has a Return On Equity of 12.98%. This is amongst the best in the industry. AKE outperforms 95.04% of its industry peers.
  • AKE has a better Return On Invested Capital (12.94%) than 97.76% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for AKE is significantly below the industry average of 12.22%.
  • The 3 year average ROIC (6.50%) for AKE is below the current ROIC(12.94%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.47%
ROE 12.98%
ROIC 12.94%
ROA(3y)3.62%
ROA(5y)2.24%
ROE(3y)4.75%
ROE(5y)2.86%
ROIC(3y)6.5%
ROIC(5y)N/A
AKE.CA Yearly ROA, ROE, ROICAKE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10

1.3 Margins

  • The Profit Margin of AKE (36.57%) is better than 98.58% of its industry peers.
  • AKE's Profit Margin has improved in the last couple of years.
  • AKE has a Operating Margin of 72.27%. This is amongst the best in the industry. AKE outperforms 99.76% of its industry peers.
  • AKE has a Gross Margin of 84.30%. This is amongst the best in the industry. AKE outperforms 99.29% of its industry peers.
  • AKE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 72.27%
PM (TTM) 36.57%
GM 84.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y27.05%
GM growth 3Y136.76%
GM growth 5Y26.6%
AKE.CA Yearly Profit, Operating, Gross MarginsAKE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AKE is creating some value.
  • AKE has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for AKE has been reduced compared to a year ago.
AKE.CA Yearly Shares OutstandingAKE.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
AKE.CA Yearly Total Debt VS Total AssetsAKE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

  • AKE has an Altman-Z score of 2.56. This is not the best score and indicates that AKE is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.56, AKE is in line with its industry, outperforming 56.79% of the companies in the same industry.
  • AKE has a debt to FCF ratio of 1.28. This is a very positive value and a sign of high solvency as it would only need 1.28 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 1.28, AKE belongs to the best of the industry, outperforming 95.28% of the companies in the same industry.
  • A Debt/Equity ratio of 0.08 indicates that AKE is not too dependend on debt financing.
  • The Debt to Equity ratio of AKE (0.08) is worse than 67.06% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for AKE, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.28
Altman-Z 2.56
ROIC/WACC1.48
WACC8.75%
AKE.CA Yearly LT Debt VS Equity VS FCFAKE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 2.52 indicates that AKE has no problem at all paying its short term obligations.
  • AKE has a Current ratio of 2.52. This is comparable to the rest of the industry: AKE outperforms 50.06% of its industry peers.
  • A Quick Ratio of 2.23 indicates that AKE has no problem at all paying its short term obligations.
  • AKE has a Quick ratio (2.23) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.52
Quick Ratio 2.23
AKE.CA Yearly Current Assets VS Current LiabilitesAKE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 28.94% over the past year.
  • Measured over the past years, AKE shows a very strong growth in Earnings Per Share. The EPS has been growing by 142.97% on average per year.
  • Looking at the last year, AKE shows a very strong growth in Revenue. The Revenue has grown by 62.19%.
  • Measured over the past years, AKE shows a very strong growth in Revenue. The Revenue has been growing by 133.56% on average per year.
EPS 1Y (TTM)28.94%
EPS 3YN/A
EPS 5Y142.97%
EPS Q2Q%-9.87%
Revenue 1Y (TTM)62.19%
Revenue growth 3Y150.24%
Revenue growth 5Y133.56%
Sales Q2Q%15.2%

3.2 Future

  • The Earnings Per Share is expected to grow by 0.91% on average over the next years.
  • The Revenue is expected to grow by 8.16% on average over the next years. This is quite good.
EPS Next Y-17.91%
EPS Next 2Y-1.44%
EPS Next 3Y12.46%
EPS Next 5Y0.91%
Revenue Next Year-5.44%
Revenue Next 2Y4.69%
Revenue Next 3Y11.08%
Revenue Next 5Y8.16%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AKE.CA Yearly Revenue VS EstimatesAKE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
AKE.CA Yearly EPS VS EstimatesAKE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 9.53 indicates a reasonable valuation of AKE.
  • Based on the Price/Earnings ratio, AKE is valued cheaply inside the industry as 94.57% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.64, AKE is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 11.57, the valuation of AKE can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, AKE is valued cheaply inside the industry as 92.21% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of AKE to the average of the S&P500 Index (27.75), we can say AKE is valued rather cheaply.
Industry RankSector Rank
PE 9.53
Fwd PE 11.57
AKE.CA Price Earnings VS Forward Price EarningsAKE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, AKE is valued cheaply inside the industry as 95.16% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.7
EV/EBITDA N/A
AKE.CA Per share dataAKE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • AKE has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as AKE's earnings are expected to grow with 12.46% in the coming years.
PEG (NY)N/A
PEG (5Y)0.07
EPS Next 2Y-1.44%
EPS Next 3Y12.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • AKE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

Alikem Limited

TSX:AKE (12/21/2023, 7:00:00 PM)

8.86

-0.05 (-0.56%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A
Earnings (Next)01-04
Inst Owners21.93%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.68B
Revenue(TTM)1.21B
Net Income(TTM)441.71M
Analysts78.1
Price Target12.46 (40.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.36%
PT rev (3m)-18.73%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-25.58%
EPS NY rev (3m)-39.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-19.99%
Revenue NY rev (3m)-28.73%
Valuation
Industry RankSector Rank
PE 9.53
Fwd PE 11.57
P/S 3.55
P/FCF 16.7
P/OCF 5.42
P/B 1.26
P/tB 1.49
EV/EBITDA N/A
EPS(TTM)0.93
EY10.5%
EPS(NY)0.77
Fwd EY8.64%
FCF(TTM)0.53
FCFY5.99%
OCF(TTM)1.63
OCFY18.45%
SpS2.5
BVpS7.03
TBVpS5.96
PEG (NY)N/A
PEG (5Y)0.07
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 8.47%
ROE 12.98%
ROCE 18.29%
ROIC 12.94%
ROICexc 15.63%
ROICexgc 18.01%
OM 72.27%
PM (TTM) 36.57%
GM 84.3%
FCFM 21.25%
ROA(3y)3.62%
ROA(5y)2.24%
ROE(3y)4.75%
ROE(5y)2.86%
ROIC(3y)6.5%
ROIC(5y)N/A
ROICexc(3y)7.8%
ROICexc(5y)N/A
ROICexgc(3y)9.02%
ROICexgc(5y)N/A
ROCE(3y)9.19%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y27.05%
GM growth 3Y136.76%
GM growth 5Y26.6%
F-Score8
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.28
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 44.23%
Interest Coverage -62.06
Cash Conversion N/A
Profit Quality 58.11%
Current Ratio 2.52
Quick Ratio 2.23
Altman-Z 2.56
F-Score8
WACC8.75%
ROIC/WACC1.48
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)64.83%
Cap/Sales(5y)84.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.94%
EPS 3YN/A
EPS 5Y142.97%
EPS Q2Q%-9.87%
EPS Next Y-17.91%
EPS Next 2Y-1.44%
EPS Next 3Y12.46%
EPS Next 5Y0.91%
Revenue 1Y (TTM)62.19%
Revenue growth 3Y150.24%
Revenue growth 5Y133.56%
Sales Q2Q%15.2%
Revenue Next Year-5.44%
Revenue Next 2Y4.69%
Revenue Next 3Y11.08%
Revenue Next 5Y8.16%
EBIT growth 1Y87.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-19.97%
EBIT Next 3Y10.39%
EBIT Next 5Y7.54%
FCF growth 1Y42.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y79.1%
OCF growth 3YN/A
OCF growth 5YN/A

Alikem Limited / AKE.CA FAQ

What is the fundamental rating for AKE stock?

ChartMill assigns a fundamental rating of 6 / 10 to AKE.CA.


Can you provide the valuation status for Alikem Limited?

ChartMill assigns a valuation rating of 6 / 10 to Alikem Limited (AKE.CA). This can be considered as Fairly Valued.


How profitable is Alikem Limited (AKE.CA) stock?

Alikem Limited (AKE.CA) has a profitability rating of 7 / 10.


Can you provide the financial health for AKE stock?

The financial health rating of Alikem Limited (AKE.CA) is 7 / 10.